CymitQuimica logo

CAS 536745-81-0

:

Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
  • C17 Globotriaosylceramide (d18:1/17:0)
    Targetmol
    + Info

    C17 Globotriaosylceramide (d18:1/17:0)

    CAS:
    <p>C17 Globotriaosylceramide, a sphingolipid, serves as an internal standard in Fabry disease plasma/urine quantification via GC-MS.</p>
    Formula:C53H99NO18
    Color and Shape:Solid
    Molecular weight:1038.364

    Ref: TM-T37438

  • C17 Globotriaosylceramide (d18:1/17:0)
    Larodan
    + Info

    C17 Globotriaosylceramide (d18:1/17:0)

    CAS:
    Formula:C53H99NO18
    Purity:>98%
    Color and Shape:Solid
    Molecular weight:1038.35

    Ref: 48-56-5217

    500µg
    765.00€
  • Heptadecanoyl ceramide trihexoside (C17 CTH)
    Larodan
    + Info

    Heptadecanoyl ceramide trihexoside (C17 CTH)

    CAS:
    Formula:C53H99NO18
    Purity:>99%
    Color and Shape:Solid
    Molecular weight:1038.35

    Ref: 48-56-1061

    500µg
    678.00€
  • Globotriaosylceramide
    Biosynth
    + Info

    Globotriaosylceramide

    CAS:
    <p>Globotriaosylceramide (Gb3) is a glycolipid that has been shown to be an activator of the protein growth factor-β1. It is involved in the regulation of tumor cell proliferation and may have potential as a biomarker for cancer. Gb3 is also a drug transporter and it has been shown to have long-term efficacy in the treatment of sarcoidosis. Gb3 has been found in high concentrations in patients with HIV infection, suggesting that it may play a role in HIV replication. Studies have also shown that Gb3 may be involved in cardiac pathology and its structural analysis can help in understanding its function. Symptoms or conditions associated with elevated levels of globotriaosylceramide include: <br>• Carcinoma<br>• Cardiac disease<br>• Infectious diseases<br>• HIV infection</p>
    Formula:C53H99NO18
    Purity:Min. 95%
    Molecular weight:1,038.35 g/mol

    Ref: 3D-OG176308

    1mg
    2,092.00€